Product Profile

FENOFIBRIC ACID Delayed-release Capsules

Equivalent of: Trilipix*
Category: Human Prescription Drug

Strength:

45 mg

FENOFIBRIC ACID Delayed-release Capsules

Product Characteristics:

brown-pink opaque, light yellow opaque
capsule
MYLAN;CF;45
Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Protect from moisture.

Packaging:

Commercial
Institutional
90
0378-2589-77
UD30 (3X10)
51079-195-03
135 mg

FENOFIBRIC ACID Delayed-release Capsules

Product Characteristics:

powder blue opaque, light yellow opaque
capsule
MYLAN;CF;135
Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Protect from moisture.

Packaging:

Commercial
Institutional
90
0378-2590-77
UD30 (3X10)
51079-196-03

Wholesale Information

Wholesaler
Code
45 mg - Delayed-release Capsules
Package/NDC: UD30 (3X10) / 51079-195-03
AmerisourceBergen
10129248
Cardinal
4939542
HD Smith
3707825
McKesson
2051332
Morris and Dickson
784108
135 mg - Delayed-release Capsules
Package/NDC: UD30 (3X10) / 51079-196-03
AmerisourceBergen
10129249
Cardinal
4939583
HD Smith
3707833
McKesson
2051324
Morris and Dickson
784983




* Registered Trademark of Abbvie Inc.